← Database
Antioxidant Tripeptide

Glutathione

Third-party suppliers · research use only · not an endorsement. Some links are affiliate links — purchases made through them may earn this site a commission.
Overview

The body's principal intracellular antioxidant — a tripeptide of glutamate, cysteine, and glycine. Widely sold as a supplement and used off-label intravenously; evidence for systemic supplementation is mixed and it is not an approved therapeutic for most of those uses.

How it works

Glutathione (GSH) is a small protein-like molecule (a tripeptide) that cells build from three amino acids — glutamate, cysteine, and glycine. It is the main antioxidant working inside cells, neutralising reactive oxygen species and helping recycle other antioxidants such as vitamins C and E.

It works as the cell's redox buffer: the sulfur-containing (–SH) group on its cysteine donates electrons to neutralise free radicals, turning into an oxidised form (GSSG) that enzymes then regenerate back to GSH using NADPH. Glutathione also tags toxins and drugs for elimination as part of the liver's phase-II detoxification.

A practical catch: swallowed glutathione is largely broken down in the gut, so oral absorption is limited, and cysteine availability often caps how much the body can make (which is why precursors like NAC are used). Evidence that systemic supplementation delivers the marketed benefits is mixed, intravenous use is off-label, and it is not an approved therapeutic for most of those claims.

Mechanism · Detailed Analysis
Molecular identityγ-L-glutamyl-L-cysteinyl-glycine — the dominant low-molecular-weight thiol antioxidant in cells, present at millimolar intracellular concentrations.
Redox cyclingThe cysteine thiol reduces reactive oxygen/nitrogen species; glutathione peroxidases oxidise GSH to GSSG, which glutathione reductase regenerates using NADPH. The GSH:GSSG ratio is a key marker of cellular redox state.
Detoxification & conjugationGlutathione-S-transferases conjugate GSH to electrophilic xenobiotics, feeding the mercapturate excretion pathway — a core phase-II detoxification route.
Pharmacology & caveatsOral GSH is substantially degraded by intestinal γ-glutamyltransferase, and synthesis is rate-limited by cysteine supply. Systemic-supplementation efficacy is debated; IV administration is off-label and unapproved for cosmetic or 'detox' indications.
Published EvidenceLoading cited studies from PubMed…
Human Data ···

Searching the published record…

Animal ···

Searching the published record…

In Vitro ···

Searching the published record…

Educational aggregation of public literature. Not medical advice and not a recommendation to use any compound. Many compounds here are not approved for human use. Consult a licensed clinician.